Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 45.84%
March 31, 2026 46.13%
December 31, 2025 43.78%
September 30, 2025 44.16%
June 30, 2025 45.16%
March 31, 2025 44.27%
December 31, 2024 44.51%
September 30, 2024 43.76%
June 30, 2024 44.76%
March 31, 2024 41.06%
December 31, 2023 43.13%
September 30, 2023 44.14%
June 30, 2023 44.62%
March 31, 2023 42.77%
December 31, 2022 42.79%
September 30, 2022 44.37%
June 30, 2022 45.02%
March 31, 2022 46.98%
December 31, 2021 44.48%
September 30, 2021 40.13%
June 30, 2021 43.95%
March 31, 2021 42.28%
December 31, 2020 42.75%
September 30, 2020 43.60%
June 30, 2020 42.91%
Date Value
March 31, 2020 44.33%
December 31, 2019 42.96%
September 30, 2019 43.26%
June 30, 2019 44.04%
March 31, 2019 43.58%
December 31, 2018 42.56%
September 30, 2018 41.98%
June 30, 2018 42.06%
March 31, 2018 40.81%
December 31, 2017 42.00%
September 30, 2017 41.98%
June 30, 2017 42.10%
March 31, 2017 41.13%
December 31, 2016 39.83%
September 30, 2016 38.32%
June 30, 2016 37.56%
March 31, 2016 38.23%
December 31, 2015 38.52%
September 30, 2015 42.79%
June 30, 2015 41.92%
March 31, 2015 42.48%
December 31, 2014 41.69%
September 30, 2014 41.93%
June 30, 2014 41.03%
March 31, 2014 41.31%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Medtronic Plc 60.80%
Trinity Biotech Plc 0.00%
ResMed, Inc. 58.12%
Alkermes Plc 75.30%
Amarin Corp. Plc 34.00%

Gross Profit Margin (Quarterly) Related Metrics